Global Long Acting Insulins Market Growth (Status and Outlook) 2022-2028

January 2021 | 60 pages | ID: G8690AB89FFEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Long Acting Insulins will have significant change from previous year. According to our (LP Information) latest study, the global Long Acting Insulins market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Long Acting Insulins market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Long Acting Insulins market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Long Acting Insulins market, reaching US$ million by the year 2028. As for the Europe Long Acting Insulins landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Long Acting Insulins players cover Novo Nordisk, Sanofi, Wockhardt UK, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Long Acting Insulins market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

• Insulin Glargine
• Insulin Determir
• Insulin Degludec
• Long Acting Animal Insulin

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

• Home Use
• Medical Institutions
• Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

• Novo Nordisk
• Sanofi
• Wockhardt UK

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Long Acting Insulins Market Size 2017-2028
  2.1.2 Long Acting Insulins Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Long Acting Insulins Segment by Type
  2.2.1 Insulin Glargine
  2.2.2 Insulin Determir
  2.2.3 Insulin Degludec
  2.2.4 Long Acting Animal Insulin
2.3 Long Acting Insulins Market Size by Type
  2.3.1 Long Acting Insulins Market Size CAGR by Type (2017 VS 2022 VS 2028)
  2.3.2 Global Long Acting Insulins Market Size Market Share by Type (2017-2022)
2.4 Long Acting Insulins Segment by Application
  2.4.1 Home Use
  2.4.2 Medical Institutions
  2.4.3 Others
2.5 Long Acting Insulins Market Size by Application
  2.5.1 Long Acting Insulins Market Size CAGR by Application (2017 VS 2022 VS 2028)
  2.5.2 Global Long Acting Insulins Market Size Market Share by Application (2017-2022)

3 LONG ACTING INSULINS MARKET SIZE BY PLAYER

3.1 Long Acting Insulins Market Size Market Share by Players
  3.1.1 Global Long Acting Insulins Revenue by Players (2020-2022)
  3.1.2 Global Long Acting Insulins Revenue Market Share by Players (2020-2022)
3.2 Global Long Acting Insulins Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 LONG ACTING INSULINS BY REGIONS

4.1 Long Acting Insulins Market Size by Regions (2017-2022)
4.2 Americas Long Acting Insulins Market Size Growth (2017-2022)
4.3 APAC Long Acting Insulins Market Size Growth (2017-2022)
4.4 Europe Long Acting Insulins Market Size Growth (2017-2022)
4.5 Middle East & Africa Long Acting Insulins Market Size Growth (2017-2022)

5 AMERICAS

5.1 Americas Long Acting Insulins Market Size by Country (2017-2022)
5.2 Americas Long Acting Insulins Market Size by Type (2017-2022)
5.3 Americas Long Acting Insulins Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Long Acting Insulins Market Size by Region (2017-2022)
6.2 APAC Long Acting Insulins Market Size by Type (2017-2022)
6.3 APAC Long Acting Insulins Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Long Acting Insulins by Country (2017-2022)
7.2 Europe Long Acting Insulins Market Size by Type (2017-2022)
7.3 Europe Long Acting Insulins Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Long Acting Insulins by Region (2017-2022)
8.2 Middle East & Africa Long Acting Insulins Market Size by Type (2017-2022)
8.3 Middle East & Africa Long Acting Insulins Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL LONG ACTING INSULINS MARKET FORECAST

10.1 Global Long Acting Insulins Forecast by Regions (2023-2028)
  10.1.1 Global Long Acting Insulins Forecast by Regions (2023-2028)
  10.1.2 Americas Long Acting Insulins Forecast
  10.1.3 APAC Long Acting Insulins Forecast
  10.1.4 Europe Long Acting Insulins Forecast
  10.1.5 Middle East & Africa Long Acting Insulins Forecast
10.2 Americas Long Acting Insulins Forecast by Country (2023-2028)
  10.2.1 United States Long Acting Insulins Market Forecast
  10.2.2 Canada Long Acting Insulins Market Forecast
  10.2.3 Mexico Long Acting Insulins Market Forecast
  10.2.4 Brazil Long Acting Insulins Market Forecast
10.3 APAC Long Acting Insulins Forecast by Region (2023-2028)
  10.3.1 China Long Acting Insulins Market Forecast
  10.3.2 Japan Long Acting Insulins Market Forecast
  10.3.3 Korea Long Acting Insulins Market Forecast
  10.3.4 Southeast Asia Long Acting Insulins Market Forecast
  10.3.5 India Long Acting Insulins Market Forecast
  10.3.6 Australia Long Acting Insulins Market Forecast
10.4 Europe Long Acting Insulins Forecast by Country (2023-2028)
  10.4.1 Germany Long Acting Insulins Market Forecast
  10.4.2 France Long Acting Insulins Market Forecast
  10.4.3 UK Long Acting Insulins Market Forecast
  10.4.4 Italy Long Acting Insulins Market Forecast
  10.4.5 Russia Long Acting Insulins Market Forecast
10.5 Middle East & Africa Long Acting Insulins Forecast by Region (2023-2028)
  10.5.1 Egypt Long Acting Insulins Market Forecast
  10.5.2 South Africa Long Acting Insulins Market Forecast
  10.5.3 Israel Long Acting Insulins Market Forecast
  10.5.4 Turkey Long Acting Insulins Market Forecast
  10.5.5 GCC Countries Long Acting Insulins Market Forecast
10.6 Global Long Acting Insulins Forecast by Type (2023-2028)
10.7 Global Long Acting Insulins Forecast by Application (2023-2028)

11 KEY PLAYERS ANALYSIS

11.1 Novo Nordisk
  11.1.1 Novo Nordisk Company Information
  11.1.2 Novo Nordisk Long Acting Insulins Product Offered
  11.1.3 Novo Nordisk Long Acting Insulins Revenue, Gross Margin and Market Share (2020-2022)
  11.1.4 Novo Nordisk Main Business Overview
  11.1.5 Novo Nordisk Latest Developments
11.2 Sanofi
  11.2.1 Sanofi Company Information
  11.2.2 Sanofi Long Acting Insulins Product Offered
  11.2.3 Sanofi Long Acting Insulins Revenue, Gross Margin and Market Share (2020-2022)
  11.2.4 Sanofi Main Business Overview
  11.2.5 Sanofi Latest Developments
11.3 Wockhardt UK
  11.3.1 Wockhardt UK Company Information
  11.3.2 Wockhardt UK Long Acting Insulins Product Offered
  11.3.3 Wockhardt UK Long Acting Insulins Revenue, Gross Margin and Market Share (2020-2022)
  11.3.4 Wockhardt UK Main Business Overview
  11.3.5 Wockhardt UK Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Long Acting Insulins Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Insulin Glargine
Table 3. Major Players of Insulin Determir
Table 4. Major Players of Insulin Degludec
Table 5. Major Players of Long Acting Animal Insulin
Table 6. Long Acting Insulins Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Long Acting Insulins Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Long Acting Insulins Market Size Market Share by Type (2017-2022)
Table 9. Long Acting Insulins Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Long Acting Insulins Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Long Acting Insulins Market Size Market Share by Application (2017-2022)
Table 12. Global Long Acting Insulins Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Long Acting Insulins Revenue Market Share by Player (2020-2022)
Table 14. Long Acting Insulins Key Players Head office and Products Offered
Table 15. Long Acting Insulins Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Long Acting Insulins Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Long Acting Insulins Market Size Market Share by Regions (2017-2022)
Table 20. Americas Long Acting Insulins Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Long Acting Insulins Market Size Market Share by Country (2017-2022)
Table 22. Americas Long Acting Insulins Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Long Acting Insulins Market Size Market Share by Type (2017-2022)
Table 24. Americas Long Acting Insulins Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Long Acting Insulins Market Size Market Share by Application (2017-2022)
Table 26. APAC Long Acting Insulins Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Long Acting Insulins Market Size Market Share by Region (2017-2022)
Table 28. APAC Long Acting Insulins Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Long Acting Insulins Market Size Market Share by Type (2017-2022)
Table 30. APAC Long Acting Insulins Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Long Acting Insulins Market Size Market Share by Application (2017-2022)
Table 32. Europe Long Acting Insulins Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Long Acting Insulins Market Size Market Share by Country (2017-2022)
Table 34. Europe Long Acting Insulins Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Long Acting Insulins Market Size Market Share by Type (2017-2022)
Table 36. Europe Long Acting Insulins Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Long Acting Insulins Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Long Acting Insulins Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Long Acting Insulins Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Long Acting Insulins Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Long Acting Insulins Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Long Acting Insulins Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Long Acting Insulins Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Long Acting Insulins
Table 45. Key Market Challenges & Risks of Long Acting Insulins
Table 46. Key Industry Trends of Long Acting Insulins
Table 47. Global Long Acting Insulins Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Long Acting Insulins Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Long Acting Insulins Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Long Acting Insulins Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Long Acting Insulins Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Long Acting Insulins Market Size Market Share Forecast by Application (2023-2028)
Table 53. Novo Nordisk Details, Company Type, Long Acting Insulins Area Served and Its Competitors
Table 54. Novo Nordisk Long Acting Insulins Product Offered
Table 55. Novo Nordisk Long Acting Insulins Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Novo Nordisk Main Business
Table 57. Novo Nordisk Latest Developments
Table 58. Sanofi Details, Company Type, Long Acting Insulins Area Served and Its Competitors
Table 59. Sanofi Long Acting Insulins Product Offered
Table 60. Sanofi Main Business
Table 61. Sanofi Long Acting Insulins Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Sanofi Latest Developments
Table 63. Wockhardt UK Details, Company Type, Long Acting Insulins Area Served and Its Competitors
Table 64. Wockhardt UK Long Acting Insulins Product Offered
Table 65. Wockhardt UK Main Business
Table 66. Wockhardt UK Long Acting Insulins Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Wockhardt UK Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Long Acting Insulins Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Long Acting Insulins Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Long Acting Insulins Market Size Market Share by Type in 2021
Figure 7. Long Acting Insulins in Home Use
Figure 8. Global Long Acting Insulins Market: Home Use (2017-2022) & ($ Millions)
Figure 9. Long Acting Insulins in Medical Institutions
Figure 10. Global Long Acting Insulins Market: Medical Institutions (2017-2022) & ($ Millions)
Figure 11. Long Acting Insulins in Others
Figure 12. Global Long Acting Insulins Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Long Acting Insulins Market Size Market Share by Application in 2021
Figure 14. Global Long Acting Insulins Revenue Market Share by Player in 2021
Figure 15. Global Long Acting Insulins Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Long Acting Insulins Market Size 2017-2022 ($ Millions)
Figure 17. APAC Long Acting Insulins Market Size 2017-2022 ($ Millions)
Figure 18. Europe Long Acting Insulins Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Long Acting Insulins Market Size 2017-2022 ($ Millions)
Figure 20. Americas Long Acting Insulins Value Market Share by Country in 2021
Figure 21. Americas Long Acting Insulins Consumption Market Share by Type in 2021
Figure 22. Americas Long Acting Insulins Market Size Market Share by Application in 2021
Figure 23. United States Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Long Acting Insulins Market Size Market Share by Region in 2021
Figure 28. APAC Long Acting Insulins Market Size Market Share by Application in 2021
Figure 29. China Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Long Acting Insulins Market Size Market Share by Country in 2021
Figure 36. Europe Long Acting Insulins Market Size Market Share by Type in 2021
Figure 37. Europe Long Acting Insulins Market Size Market Share by Application in 2021
Figure 38. Germany Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Long Acting Insulins Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Long Acting Insulins Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Long Acting Insulins Market Size Market Share by Application in 2021
Figure 46. Egypt Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Long Acting Insulins Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 52. APAC Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 53. Europe Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 55. United States Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 56. Canada Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 59. China Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 60. Japan Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 61. Korea Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 63. India Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 64. Australia Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 65. Germany Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 66. France Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 67. UK Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 68. Italy Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 69. Russia Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 70. Spain Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 73. Israel Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Long Acting Insulins Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Long Acting Insulins Market Size 2023-2028 ($ Millions)